Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer (NY: PFE ) 25.40 +0.14 (+0.55%) Official Closing Price Updated: 7:00 PM EDT, Apr 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 46,526,519 Open 25.33 Bid (Size) 25.41 (2) Ask (Size) 25.45 (9) Prev. Close 25.26 Today's Range 25.20 - 25.54 52wk Range 25.20 - 40.37 Shares Outstanding 5,606,688,356 Dividend Yield 6.46% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Dividend Stocks to Buy and Hold for the Next Decade Today 7:15 EDT You'll get dividends and more with these great stocks. Via The Motley Fool 7 Dividend Stocks to Buy Now for Steady Returns in Any Market Today 6:00 EDT Passive investors pay attention! Invest in the best of the best with these seven dividend stocks for steady returns. Via InvestorPlace Performance YTD -14.56% -14.56% 1 Month -8.57% -8.57% 3 Month -7.54% -7.54% 6 Month -15.64% -15.64% 1 Year -34.43% -34.43% More News Read More COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle April 26, 2024 Via Benzinga Topics Intellectual Property Lawsuit Exposures COVID-19 Financial Intellectual Property FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia April 26, 2024 Via Benzinga Exposures Product Safety Pfizer's Options: A Look at What the Big Money is Thinking April 26, 2024 Via Benzinga Creative Biolabs: The Way ADCs Are Made Has Changed April 23, 2024 Via Get News US Stock: Pfizer April 23, 2024 Via Talk Markets Pfizer Options Trading: A Deep Dive into Market Sentiment April 22, 2024 Via Benzinga Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks April 26, 2024 Via The Motley Fool Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy April 26, 2024 Via Investor's Business Daily Exposures Product Safety U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B April 26, 2024 From Pfizer Inc. Via Business Wire What's Going On With Pfizer Stock On Thursday? April 25, 2024 Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property 3 Bargain Stocks Near 52-week Lows April 25, 2024 Via MarketBeat Topics Economy Exposures Interest Rates Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market April 25, 2024 Via Investor's Business Daily Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields April 25, 2024 Via Benzinga Pfizer Declares Second-Quarter 2024 Dividend April 24, 2024 From Pfizer Inc. Via Business Wire The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth April 24, 2024 Via InvestorPlace 3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains April 24, 2024 Via InvestorPlace 3 Defensive Stocks To Protect Your Portfolio In 2024 April 23, 2024 Via Talk Markets Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown April 23, 2024 Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property 3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge April 23, 2024 Via InvestorPlace Better Buy: Pfizer vs. Viking Therapeutics April 23, 2024 Via The Motley Fool 1 No-Brainer Vanguard Fund to Buy Right Now April 23, 2024 Via The Motley Fool 3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years April 22, 2024 Via InvestorPlace European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options April 22, 2024 From Pfizer Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.